Drug target for aggressive breast cancer found
A team of British and American scientists have discovered a way to slow the growth of breast cancer stem cells in the lab
A team of British and American scientists have discovered a way to slow the growth of breast cancer stem cells in the lab
Using the ‘Balds eyesalve’ medieval mixture containing every day natural ingredients such as garlic, researchers from the University of Warwick have found it was effective against five bacteria that cause modern day biofilm infections
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
Matrix Instrument Data Acquisition System (MIDAS) extended to drive integration and automation from a wide selection of laboratory instruments
The FluidFM BOT BIO Series combines Olympus’ renowned optics with Cytosurge’s cell manipulation expertise
BASF to utilize Tropic Bio's GEiGS (Gene Editing induced Gene Silencing) technology to develop strategic crop varieties with improved resistance to disease and pests
Researchers from the University of Oxford’s Department of Zoology have discovered that moderate doses of antibiotics restrict the emergence of antibiotic-resistant bacteria
This evidence-based programme, called SHAPE Recovery, builds on an outreach programme shown to reduce rates of PTSD and depression
When patients report muscle-related symptoms, blood tests can provide reassurance about continuing statin therapy to help prevent heart attacks and strokes
This support will contribute to the measures against COVID-19, following provision of medical equipment and supplies, employee donations, and loans through NPO
Thermo Fisher Scientific’s ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites
Discover how light scattering provides essential biophysical insight and reliable quantification of critical quality parameters for vaccine research, development, production and quality control
Partnership to co-commercialize pralsetinib, an investigational, precision therapy in late-stage development
AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage
Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)
Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus
The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes
ETH researchers have used computer simulations to classify the current activity of corona structures on the surface of Venus
Magnetic nanodiscs can be activated by an external magnetic field, providing a research tool for studying neural responses